Federal contract award
W911NF25PA013
THIS SMALL BUSINESS INNOVATION RESEARCH PHASE I PROPOSAL WILL FOCUS ON DEVELOPING A DEOXYRIBONUCLEIC ACID BASED BINDER OF NEUROTOXINS THAT ALSO CATALYZES DEACTIVATION OF THE AGENT, RENDERING IT INEFFECTIVE AS A WARFARE WEAPON.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W6QK ACC-APG DURHAM |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AJ11 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $209.6K |
| Current contract value | $209.6K |
| Potential contract value / ceiling | $209.6K |
| Start date | Aug 1, 2025 |
| Current end date | Feb 28, 2026 |
| Potential end date | Feb 28, 2026 |
| Latest award activity | Jan 26, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 26, 2026 | P00002 | $0 | THIS SMALL BUSINESS INNOVATION RESEARCH PHASE I PROPOSAL WILL FOCUS ON DEVELOPING A DEOXYRIBONUCLEIC ACID BASED BINDER OF NEUROTOXINS THAT ALSO CATALYZES DEACTIVATION OF THE AGENT, RENDERING IT INEFFECTIVE AS A WARFARE WEAPON. |
| Nov 20, 2025 | P00001 | $0 | THIS SMALL BUSINESS INNOVATION RESEARCH PHASE I PROPOSAL WILL FOCUS ON DEVELOPING A DEOXYRIBONUCLEIC ACID BASED BINDER OF NEUROTOXINS THAT ALSO CATALYZES DEACTIVATION OF THE AGENT, RENDERING IT INEFFECTIVE AS A WARFARE WEAPON. |
| Jul 23, 2025 | 0 | $209.6K | THIS SMALL BUSINESS INNOVATION RESEARCH PHASE I PROPOSAL WILL FOCUS ON DEVELOPING A DEOXYRIBONUCLEIC ACID BASED BINDER OF NEUROTOXINS THAT ALSO CATALYZES DEACTIVATION OF THE AGENT, RENDERING IT INEFFECTIVE AS A WARFARE WEAPON. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.